[go: up one dir, main page]

HK1211361A1 - Disease progression parameters and uses thereof for evaluating multiple sclerosis - Google Patents

Disease progression parameters and uses thereof for evaluating multiple sclerosis Download PDF

Info

Publication number
HK1211361A1
HK1211361A1 HK15112164.8A HK15112164A HK1211361A1 HK 1211361 A1 HK1211361 A1 HK 1211361A1 HK 15112164 A HK15112164 A HK 15112164A HK 1211361 A1 HK1211361 A1 HK 1211361A1
Authority
HK
Hong Kong
Prior art keywords
disease progression
multiple sclerosis
evaluating multiple
progression parameters
parameters
Prior art date
Application number
HK15112164.8A
Other languages
English (en)
Chinese (zh)
Inventor
Diego CADAVID
Deborah Ann KINCH
Sophia Lee
Lei Xu
Original Assignee
Biogen Ma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc. filed Critical Biogen Ma Inc.
Publication of HK1211361A1 publication Critical patent/HK1211361A1/xx

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Surgery (AREA)
  • Primary Health Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Developmental Disabilities (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15112164.8A 2012-08-13 2013-08-08 Disease progression parameters and uses thereof for evaluating multiple sclerosis HK1211361A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261682521P 2012-08-13 2012-08-13
US61/682,521 2012-08-13
PCT/US2013/054128 WO2014028299A1 (en) 2012-08-13 2013-08-08 Disease progression parameters and uses thereof for evaluating multiple sclerosis

Publications (1)

Publication Number Publication Date
HK1211361A1 true HK1211361A1 (en) 2016-05-20

Family

ID=49004015

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112164.8A HK1211361A1 (en) 2012-08-13 2013-08-08 Disease progression parameters and uses thereof for evaluating multiple sclerosis

Country Status (4)

Country Link
US (1) US20150220693A1 (xx)
EP (1) EP2883177A1 (xx)
HK (1) HK1211361A1 (xx)
WO (1) WO2014028299A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717453B2 (en) 2012-04-20 2017-08-01 Biogen Idec Ma Inc. Cognitive composite parameters and uses thereof for evaluating multiple sclerosis
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
WO2015130998A1 (en) 2014-02-28 2015-09-03 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
WO2016040861A1 (en) * 2014-09-12 2016-03-17 Biogen Ma Inc. Systems and methods for characterization of multiple sclerosis
MY188764A (en) 2014-12-11 2021-12-30 Actelion Pharmaceuticals Ltd Dosing regimen for a selective s1p1 receptor agonist
MA41139A (fr) 2014-12-11 2017-10-17 Actelion Pharmaceuticals Ltd Combinaison pharmaceutique comportant un agoniste sélectif du récepteur sip1
HK1246810A1 (zh) 2015-01-08 2018-09-14 Biogen Ma Inc. Lingo-1对抗药及用於治疗脱髓鞘疾病的用途
CN108198615B (zh) * 2016-05-09 2020-09-11 南京智精灵教育科技有限公司 一种在线认知评估系统
US11056218B2 (en) * 2016-05-31 2021-07-06 International Business Machines Corporation Identifying personalized time-varying predictive patterns of risk factors
CN109688926B (zh) * 2016-09-14 2022-09-13 豪夫迈·罗氏有限公司 用于认知和运动疾病或障碍的数字生物标记
DE202017007239U1 (de) * 2016-09-14 2020-03-16 F. Hoffmann-La Roche Ag Digitale Biomarker für progrediente MS
US10832815B2 (en) 2017-05-18 2020-11-10 International Business Machines Corporation Medical side effects tracking
US11363970B2 (en) * 2017-10-10 2022-06-21 Hunter Cronin Hand-held dexterity testing apparatus
WO2019081640A2 (en) * 2017-10-25 2019-05-02 F. Hoffmann-La Roche Ag DIGITAL QUALIMETRIC BIOMARKERS FOR DISEASES OR DISORDERS OF COGNITION AND MOVEMENT
CN113661543A (zh) * 2019-02-06 2021-11-16 诺华股份有限公司 用于确定患者的多发性硬化的状态的技术
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
US20210407629A1 (en) * 2020-06-24 2021-12-30 F. Hoffmann-La Roche Ltd. Compromised-system assessments based on key translation
EP4315364A1 (en) * 2021-03-30 2024-02-07 F. Hoffmann-La Roche AG Computer-implemented methods and systems for quantitatively determining a clinical parameter
US12353369B2 (en) * 2021-04-30 2025-07-08 University Of Maryland, Baltimore County Systems and methods of analyzing user-entered or machine-generated values in data for determining defective entries
CN113782141B (zh) * 2021-08-11 2023-12-19 中国中医科学院中医药信息研究所 临床研究中联合干预疗效计算方法、装置及存储介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE182625T1 (de) 1993-01-12 1999-08-15 Biogen Inc Rekombinante anti-vla4 antikörpermoleküle
JP3593343B2 (ja) 1993-02-09 2004-11-24 バイオジェン インコーポレイテッド インシュリン依存型糖尿病の治療
US5840299A (en) 1994-01-25 1998-11-24 Athena Neurosciences, Inc. Humanized antibodies against leukocyte adhesion molecule VLA-4
WO2009111886A1 (en) * 2008-03-14 2009-09-17 Stresscam Operations & Systems Ltd. Assessment of medical conditions by determining mobility
WO2010005570A2 (en) 2008-07-09 2010-01-14 Biogen Idec Ma Inc. Compositions comprising antibodies to lingo or fragments thereof
US8906357B2 (en) * 2010-04-20 2014-12-09 Ab Science Treatment of multiple sclerosis with masitinib
US9872637B2 (en) * 2010-04-21 2018-01-23 The Rehabilitation Institute Of Chicago Medical evaluation system and method using sensors in mobile devices
BR112013019683B1 (pt) 2011-02-07 2022-04-19 Biogen Inc Compostos que modulam s1p, composição farmacêutica, e uso dos mesmos

Also Published As

Publication number Publication date
US20150220693A1 (en) 2015-08-06
WO2014028299A1 (en) 2014-02-20
EP2883177A1 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
HK1211361A1 (en) Disease progression parameters and uses thereof for evaluating multiple sclerosis
EP2737829A4 (en) BED COMBINATION PROCESS, BREADING METHOD AND BED
PL2819853T3 (pl) Sposób wytwarzania polimerów dienowych
SG11201406026TA (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
HUE039225T2 (hu) Nagy szilárdságú rugóacél, nagy szilárdságú rugó elõállítására szolgáló eljárás, valamint nagy szilárdságú rugó
IL238067A0 (en) Compositions, structures and methods for neural regeneration
HK1213046A1 (zh) 動態bh3分析
EP2702005A4 (en) GRAPHENEAN BANDERS, METHOD OF MANUFACTURING THEREOF AND USES THEREOF
PL2674034T3 (pl) Sposób wytwarzania oleju z kryla i olej z kryla wytwarzany tym sposobem
GB201503663D0 (en) Systems and methods for diagnosing strokes
EP2906794A4 (en) SELF-ORIENTING PISTON AND METHOD OF MANUFACTURING THEREOF
EP3012341A4 (en) Zinc-induced-crack resistant steel plate and manufacturing method therefor
IL238187B (en) Membranes of polyaniline, uses and methods thereof
WO2012150341A3 (de) Verfahren zur erfassung eines von einer ersten einheit zu einer zweiten einheit transferierbaren, mengenmässig bestimmbaren mediums
EP2648105B8 (en) Database performance analysis
WO2014145203A3 (en) Systems and methods for characterization of multiple sclerosis
GB2519260B (en) Well tool pressure testing
EP2868508A4 (en) COMMERCIAL VEHICLE AND MANUFACTURING METHOD FOR THE COMMERCIAL VEHICLE
IL236436A0 (en) Kits and methods for the detection of cyanide
SG11201406453WA (en) Rubber compounding oil and method for manufacturing the same
EP2820414A4 (en) METHOD AND KITS FOR DETECTING AND DIAGNOSIS OF NEUROTRAUMATA
SG11201404714YA (en) Conjugated diene polymer production method, and conjugated diene polymer composition production method
EP2883888A4 (en) ELASTOMERES TERPOLYMER WITH A DIENMONOMER AND METHOD OF MANUFACTURING THEREOF
EP2980228A4 (en) Steel sheet and manufacturing method therefor
BR112014010314A2 (pt) método de carbonituração com baixa pressão